Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript

Group 1 - The company has focused on execution and streamlined its business through a cost takeout initiative implemented in December [1] - A significant amount of time has been spent addressing tariffs, particularly concerning syringe products manufactured in China [2] - The company plans to cease production in China by June and has successfully transitioned syringe production to Mexico and Cambodia, indicating progress ahead of schedule [2]